A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

INTRODUCTION: Components of the hedgehog signaling pathway are upregulated in patients with idiopathic pulmonary fibrosis (IPF). Vismodegib, a small-molecule inhibitor of hedgehog signaling, when used in combination with currently available antifibrotic therapy, may be more efficacious than antifibr...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasse, Antje, Ramaswamy, Murali, Mohan, Shaun, Pan, Lin, Kenwright, Andrew, Neighbors, Margaret, Belloni, Paula, LaCamera, Peter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967289/
https://www.ncbi.nlm.nih.gov/pubmed/32026407
http://dx.doi.org/10.1007/s41030-019-0096-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967289/
https://www.ncbi.nlm.nih.gov/pubmed/32026407
http://dx.doi.org/10.1007/s41030-019-0096-8

Ejemplares similares